Successful global trial experience in Asia Pacific region

1.   Respiratory phase IIIb trial (global project):

   over 2000 patients，43 hospitals，44 sites, 10 cities.

2.   Cardiovascular Phase I trial (global):

   over 200 healthy volunteers, 2 phase I units in 2 hospitals.

3.   Anti-infective phase I trial (global):

   over 60 healthy volunteers, a phase I unit in a hospital.

4.   Cardiovascular phase I trial (global):

   over 50 healthy volunteers, a phase I unit in a hospital.

5.   Cerebrovascular phase II trial (global): 

   over 30 patients, 2 sites.

6.   Cardiovascular phase II trial (global):

   over 200 patients, 5 sites

7.   Diabetic phase III trial (global):

   over 200 patients, 8 hospitals

8.   Oncology phase III trial (global):

   over 30 patients, 4 sites.

9.   Respiratory phase III trial (global):

   over 20 patients, 3 sites.

10.  Gastroenterology phase IV trial (global):

   over 150 patients, 6 sites.

11.  Psychiatric phase IV trial (global):

   over 100 patients, 2 sites.

12.  Cardiovascular phase IV trial (global):

   over 200 patients, 5 sites.

13.  Gastroenterology phase IV trial (global):

   over 120 patients, 3 sites.